Literature DB >> 28357103

VEGF, Flt-1, and microvessel density in primary tumors as predictive factors of colorectal cancer prognosis.

Justyna Zygoń1, Mariusz Szajewski2, Wiesław Janusz Kruszewski2, Robert Rzepko3.   

Abstract

Angiogenesis in the primary tumor is known to be necessary for tumor progression in adenocarcinomas of the colon. However, whether angiogenesis in the primary tumors of patients with colorectal cancer affects their prognosis has yet to be fully elucidated. The aim of the present study was to assess the association between selected pathoclinical parameters and overall survival of resectable colorectal cancer patients with the expression of angiogenesis-promoting factors, including vascular endothelial growth factor (VEGF) and Fms-like tyrosine kinase receptor (Flt-1), and microvessel density (MVD) in the primary tumor. VEGF and Flt-1 expression were assessed, as well as MVD (with anti-CD34) by immunohistochemistry in 139 archived primary colorectal cancer tissue samples. These results were compared with the overall survival of the patients and potential prognostic pathoclinical parameters. A higher MVD in the tumors expressing Flt-1 (P=0.04) was identified. However, there was no correlation between the pathoclinical parameters of colon cancer and Flt-1 expression, VEGF expression, or MVD in the tumor. Furthermore, the intensity of VEGF expression, Flt-1 expression and tumor MVD did not correlate with the overall survival of the patients. Therefore, although increased expression of VEGF and Flt-1 was correlated with an increased expression of MVD in the primary tumors of resectable colorectal cancer patients, these factors were not correlated with prognostic pathoclinical factors and overall survival.

Entities:  

Keywords:  angiogenesis; colorectal cancer; endothelial growth factors; microvessel density; prognosis

Year:  2016        PMID: 28357103      PMCID: PMC5351762          DOI: 10.3892/mco.2016.1121

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  37 in total

1.  Identification of neovasculature using nestin in colorectal cancer.

Authors:  Nobuhisa Teranishi; Zenya Naito; Toshiyuki Ishiwata; Noritake Tanaka; Kiyonori Furukawa; Tomoko Seya; Seiichi Shinji; Takashi Tajiri
Journal:  Int J Oncol       Date:  2007-03       Impact factor: 5.650

2.  Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery.

Authors:  H Isozaki; K Okajima; Y Kawashima; S Yamada; E Nakata; J Nishimura; T Ichinona
Journal:  J Surg Oncol       Date:  1993-08       Impact factor: 3.454

3.  Angiogenesis as an unfavorable factor related to lymph node metastasis in early gastric cancer.

Authors:  C Xiangming; S Hokita; S Natsugoe; G Tanabe; M Baba; S Takao; K Kuroshima; T Aikou
Journal:  Ann Surg Oncol       Date:  1998 Oct-Nov       Impact factor: 5.344

Review 4.  CD105 is important for angiogenesis: evidence and potential applications.

Authors:  Sarah E Duff; Chenggang Li; John M Garland; Shant Kumar
Journal:  FASEB J       Date:  2003-06       Impact factor: 5.191

5.  Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.

Authors:  Y Takahashi; Y Kitadai; C D Bucana; K R Cleary; L M Ellis
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

6.  Prognostic significance of the microvascular count in colorectal cancer.

Authors:  G Lindmark; B Gerdin; C Sundberg; L Påhlman; R Bergström; B Glimelius
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

7.  Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer.

Authors:  S E Duff; M Jeziorska; S Kumar; N Haboubi; D Sherlock; S T O'Dwyer; G C Jayson
Journal:  Colorectal Dis       Date:  2007-11       Impact factor: 3.788

8.  Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma.

Authors:  Shu Zheng; Ming-Yong Han; Zuo-Xiang Xiao; Jia-Ping Peng; Qi Dong
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

Review 9.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

Review 10.  Preparing the "soil": the premetastatic niche.

Authors:  Rosandra N Kaplan; Shahin Rafii; David Lyden
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

View more
  8 in total

1.  Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC.

Authors:  Daniela Bianconi; Merima Herac; Florian Posch; Margit Schmeidl; Matthias Unseld; Markus Kieler; Robert Brettner; Leonhard Müllauer; Jakob Riedl; Armin Gerger; Werner Scheithauer; Gerald Prager
Journal:  Ther Adv Med Oncol       Date:  2020-08-18       Impact factor: 8.168

2.  HOTAIR regulates colorectal cancer stem cell properties and promotes tumorigenicity by sponging miR-211-5p and modulating FLT-1.

Authors:  Ye Huang; Liang Wang; Di Liu
Journal:  Cell Cycle       Date:  2021-09-01       Impact factor: 5.173

Review 3.  "Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer.

Authors:  Adriano Angelucci; Simona Delle Monache; Alessio Cortellini; Monica Di Padova; Corrado Ficorella
Journal:  Int J Mol Sci       Date:  2018-01-19       Impact factor: 5.923

4.  TGF-β/VEGF-A Genetic Variants Interplay in Genetic Susceptibility to Non-Melanocytic Skin Cancer.

Authors:  Letizia Scola; Maria Rita Bongiorno; Giusi Irma Forte; Anna Aiello; Giulia Accardi; Chiara Scrimali; Rossella Spina; Domenico Lio; Giuseppina Candore
Journal:  Genes (Basel)       Date:  2022-07-13       Impact factor: 4.141

5.  Trimethylamine N-Oxide Promotes Cell Proliferation and Angiogenesis in Colorectal Cancer.

Authors:  Shuyan Yang; Hui Dai; Yimei Lu; Rui Li; Chengjin Gao; Shuming Pan
Journal:  J Immunol Res       Date:  2022-07-04       Impact factor: 4.493

6.  Lymph microvascularization as a prognostic indicator in neuroblastoma.

Authors:  Irene Tadeo; Esther Gamero-Sandemetrio; Ana P Berbegall; Marta Gironella; Félix Ritort; Adela Cañete; Gloria Bueno; Samuel Navarro; Rosa Noguera
Journal:  Oncotarget       Date:  2018-05-25

7.  TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients.

Authors:  Roberto Dinami; Manuela Porru; Carla Azzurra Amoreo; Isabella Sperduti; Marcella Mottolese; Simonetta Buglioni; Daniele Marinelli; Marcello Maugeri-Saccà; Andrea Sacconi; Giovanni Blandino; Carlo Leonetti; Giuliana Di Rocco; Alessandra Verdina; Francesca Spinella; Francesco Fiorentino; Gennaro Ciliberto; Annamaria Biroccio; Pasquale Zizza
Journal:  J Exp Clin Cancer Res       Date:  2020-06-15

Review 8.  Interrogating the interplay of angiogenesis and immunity in metastatic colorectal cancer.

Authors:  Katerina Kampoli; Periklis G Foukas; Anastasios Ntavatzikos; Nikolaos Arkadopoulos; Anna Koumarianou
Journal:  World J Methodol       Date:  2022-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.